Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

AIMS: The aim was to study the prognostic value of plasma ceramides (Cer) as cardiovascular death (CV death) markers in three independent coronary artery disease (CAD) cohorts. METHODS AND RESULTS: Corogene study is a prospective Finnish cohort including stable CAD patients (n = 160). Multiple lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Laaksonen, Reijo, Ekroos, Kim, Sysi-Aho, Marko, Hilvo, Mika, Vihervaara, Terhi, Kauhanen, Dimple, Suoniemi, Matti, Hurme, Reini, März, Winfried, Scharnagl, Hubert, Stojakovic, Tatjana, Vlachopoulou, Efthymia, Lokki, Marja-Liisa, Nieminen, Markku S., Klingenberg, Roland, Matter, Christian M., Hornemann, Thorsten, Jüni, Peter, Rodondi, Nicolas, Räber, Lorenz, Windecker, Stephan, Gencer, Baris, Pedersen, Eva Ringdal, Tell, Grethe S., Nygård, Ottar, Mach, Francois, Sinisalo, Juha, Lüscher, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Fasttrack Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929378/
https://www.ncbi.nlm.nih.gov/pubmed/27125947
http://dx.doi.org/10.1093/eurheartj/ehw148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929378/
https://www.ncbi.nlm.nih.gov/pubmed/27125947
http://dx.doi.org/10.1093/eurheartj/ehw148

Ejemplares similares